| Model Number |
111815 |
| Medical Device Problem Code |
Defective Component (2292)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
06/26/2024
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
There is no evidence of quality issues associated with this complaint based on the return sample and archive sample analysis.Based on the determined risk priority number, the residual risk related to the complaint is considered acceptable.Sol millennium continues to monitor this kind of issue.Additional assessment will be taken if a significant pattern emerges.Unconfirmed.This report was initially submitted on 07/12/2024.Due to issues with displaying the initial submission, this submission contains both initial and supplemental information.
|
| |
|
Event or Problem Description
|
|
Customer says: i am sending you this email following two complaints events at the (b)(6) hospital center, about the following device: hypodermic needle 18g (1.2mm x 40mm).Sol - m.Ref: (b)(4).Lot: 02310012.Ddp: 15.10.2028.Ddf: 11.2023.I would like to ship out the devices for analysis in order to determine if there is a defect, causing the rubber coring with the antibiotic bottle.Please note that it's a recurring event.You will find in attached the screenshot of the declared issue as well as the photos of the bottle.
|
| |
|
Additional Manufacturer Narrative
|
|
(b)(4) was initiated at the manufacturing site to track the investigation and application of corrective actions associated with the event.Corrective actions include optimization of sandblasting process and equipment, increase inspection sampling frequency, and update engineering drawings to clarify sandblasting requirements.Corrective actions were verified by inspection of 3 batchs produced after improvement implementation.
|
| |
|
Additional Manufacturer Narrative
|
|
This report when initially submitted encountered an internal issue potentially related to database connectivity.This issue was identified while implementing capa-57 which was opened following an fda inspection.
|
| |
|
Search Alerts/Recalls
|